139 related articles for article (PubMed ID: 4282925)
1. In vitro cytotoxicity of normal serum factor(s) on neuraminidase-treated Ehrlich ascites tumor cells and murine leukemia L 1210 cells.
Sethi KK; Brandis H
Z Immunitatsforsch Exp Klin Immunol; 1972 May; 143(4):426-9. PubMed ID: 4282925
[No Abstract] [Full Text] [Related]
2. Antigenicity of Ehrlich ascites through neuraminidase treatment of cells.
Sur P; Roy DK
Indian J Exp Biol; 1979 Sep; 17(9):953-5. PubMed ID: 544474
[No Abstract] [Full Text] [Related]
3. Immunogenicity of leukemia L1210 cells after neuraminidase treatment.
Bekesi JG; St Arneault G; Walter L; Holland JF
J Natl Cancer Inst; 1972 Jul; 49(1):107-18. PubMed ID: 4338766
[No Abstract] [Full Text] [Related]
4. Synergistic cytotoxic effect of macrophages and normal mouse serum on neuraminidase-treated murine leukaemia cells.
Sethi KK; Brandis H
Eur J Cancer (1965); 1973; 9(11-12):809-19. PubMed ID: 4613554
[No Abstract] [Full Text] [Related]
5. Immunogenicity of L 1210 murine leukaemia cells after treatment with neuraminidase.
Bagshawe KD; Currie GA
Nature; 1968 Jun; 218(5148):1254-5. PubMed ID: 5656653
[No Abstract] [Full Text] [Related]
6. A naturally occurring complement dependent human IgM macroglobulin inhibitory to Ehrlich ascites tumor cells.
Goff MM; Armentrout SA
J Clin Lab Immunol; 1982 Dec; 9(3):163-7. PubMed ID: 7166749
[TBL] [Abstract][Full Text] [Related]
7. Interaction of syngeneic, allogeneic and xenogeneic complement with murine leukaemia and carcinoma cells in vitro [proceedings].
Peeters P; Verloes R; Atassi G; Kanarek L
Arch Int Physiol Biochim; 1979 Oct; 87(4):836-8. PubMed ID: 93935
[No Abstract] [Full Text] [Related]
8. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
Weiland E; Weiland F
Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
[No Abstract] [Full Text] [Related]
9. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
Carry PJ; Prescott DM; Ogilvie GK
Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
[TBL] [Abstract][Full Text] [Related]
10. Transplantability and antigenicity of two sublines of the TA3 tumor.
Sanford BH; Codington JF; Jeanloz RW; Palmer PD
J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
[No Abstract] [Full Text] [Related]
11. Monoclonal antibody-recognizing tumor-associated antigen of DBA/2 mouse lymphoma L1210 and its sublines.
Fuji H
Transplant Proc; 1980 Sep; 12(3):388-90. PubMed ID: 6784299
[TBL] [Abstract][Full Text] [Related]
12. Mammary tumor virus-associated antigenicity of L-1210 murine leukemia cells.
Kisielow P; Radzikowski C; Steuden J; Szkudlarek J; Krawczynski K
Arch Immunol Ther Exp (Warsz); 1971; 19(6):789-99. PubMed ID: 4335186
[No Abstract] [Full Text] [Related]
13. The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte-macrophage cooperation.
Zembala M; Ptak W; Hanczakowska M
Immunology; 1973 Oct; 25(4):631-44. PubMed ID: 4356674
[TBL] [Abstract][Full Text] [Related]
14. Cancer immunity after treatment of Ehrlich tumor with diphtheria toxin.
Buzzi S; Buzzi L
Cancer Res; 1974 Dec; 34(12):3481-6. PubMed ID: 4429964
[No Abstract] [Full Text] [Related]
15. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
Olinescu A; Hristescu S; Mazilu E
Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effectiveness of neuraminidase-treated tumor cells as an immunogen in man and experimental animals with leukemia.
Bekesi JG; Roboz JP; Holland JF
Ann N Y Acad Sci; 1976; 277(00):313-31. PubMed ID: 1069551
[TBL] [Abstract][Full Text] [Related]
17. Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment.
Bekesi JG; St-Arneault G; Holland JF
Cancer Res; 1971 Dec; 31(12):2130-2. PubMed ID: 5120303
[No Abstract] [Full Text] [Related]
18. Specific and non-specific immunotherapy of Ehrlich Ascites Carcinoma in mice.
Jakóbisiak M; Kańtoch M; Lasek W; Dobaczewska H; Obłakowski P
Folia Biol (Krakow); 1982; 30(3-4):91-7. PubMed ID: 7166197
[No Abstract] [Full Text] [Related]
19. Factors involved in the cytotoxicity of normal guinea pig serum for cells of murine tumor TA3 sublines treated with neuraminidase.
Hughes RC; Palmer PD; Sanford BH
J Immunol; 1973 Oct; 111(4):1071-80. PubMed ID: 4728677
[No Abstract] [Full Text] [Related]
20. Supression of growth of Ehrlich ascites tumor cells in mice pretreated with synthetic analogs of trehalose-6,6-dimycolate (cord factor).
Yarkoni E; Bekierkunst A; Asselineau J; Toubiana R; Toubiana MJ; Lederer E
J Natl Cancer Inst; 1973 Aug; 51(2):717-20. PubMed ID: 4765386
[No Abstract] [Full Text] [Related]
[Next] [New Search]